Join Sidley at our annual Boston Life Sciences Roundtable for an afternoon of engaging discussion addressing cutting-edge trends and hot topics.
FEATURED PANEL TOPICS
I Used To Practice Law: A Conversation with Life Sciences Leaders
A rare few life sciences leaders have served in both chief legal and chief business officer roles during the course of their careers. Join our discussion of making the transition from legal leader to business leader and the perspective that brings to a highly innovative and regulated industry.
- Anna Barry, Venture Partner, Deerfield Management
- Jerald Korn, Chief Executive Officer, Ropirio Therapeutics, Inc.
- Asher Rubin, Partner, Global Co-leader, Technology and Life Sciences Transactions
- Becky Wood, Partner, Global Co-leader, Food, Drug and Medical Device and former FDA Chief Counsel
Strategies for Success: Navigating Current Healthcare and FDA Trends for Life Sciences Companies
The session will cover hot topics and regulatory developments from both an FDA and healthcare perspective.
- Peter Smith, Head of Legal, argenx US, Inc.
- Philip Strassburger, General Counsel, Ocular Therapeutix, Inc.
- Donielle McCutcheon, Partner, Healthcare
- Jim Johnson, Partner, Food, Drug and Medical Device
Life Sciences Transactions: Updates and Perspectives on the Market
From green shoots and increased deal activity to supply chain disruptions and Congressional investigations, this panel will explore important updates affecting the environment for life sciences transactions.
- Andy Meyerson, Managing Director, Locust Walk
- Jason Russell, Managing Director, Global Head of Biotechnology, Morgan Stanley
- Rowan Walrath, Associate Editor, Chemical & Engineering News
- Michael Borden, Partner, Leader, Government Strategies
- Alison Lehner, Partner, Emerging Companies and Venture Capital
- Adriana Tibbitts, Partner, Technology and Life Sciences Transactions
